Dr. Roffler, Steve R. ’s Lab羅傅倫 博士 實驗室

HIGHLIGHT DETAIL
重要成果詳細內容


Selective Delivery of PEGylated Compounds to Tumor Cells by anti-PEG Hybrid Antibodies.

Mol Cancer Ther., Apr 07, 2015

Polyethylene glycol (PEG) is attached to many peptides, proteins, liposomes and nanoparticles to reduce their immunogenicity and improve their pharmacokinetic and therapeutic properties. Here we describe hybrid antibodies that can selectively deliver PEGylated medicines, imaging agents or nanomedicines to target cells.

Journal Link 期刊連結



Top